Sequent Scientific [SEQUENT] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Sequent Scientific Ltd.

NSE
Loading...

Divi's Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Sequent Scientific Ltd. wins in 6 metrics, Divi's Laboratories Ltd. wins in 13 metrics, with 0 ties. Divi's Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Sequent Scientific Ltd. Divi's Laboratories Ltd. Better
P/E Ratio (TTM) 123.42 67.11 Divi's Laboratories Ltd.
Price-to-Book Ratio 6.21 10.82 Sequent Scientific Ltd.
Debt-to-Equity Ratio 55.31 0.58 Divi's Laboratories Ltd.
PEG Ratio 0.23 4.63 Sequent Scientific Ltd.
EV/EBITDA 30.04 48.63 Sequent Scientific Ltd.
Profit Margin (TTM) 2.52% 24.04% Divi's Laboratories Ltd.
Operating Margin (TTM) 9.66% 29.65% Divi's Laboratories Ltd.
EBITDA Margin (TTM) 9.66% 29.65% Divi's Laboratories Ltd.
Return on Equity 6.64% 14.64% Divi's Laboratories Ltd.
Return on Assets (TTM) 4.91% 12.94% Divi's Laboratories Ltd.
Free Cash Flow (TTM) $442.73M $2.15B Divi's Laboratories Ltd.
Dividend Yield N/A 0.91% N/A
1-Year Return 26.71% -0.43% Sequent Scientific Ltd.
Price-to-Sales Ratio (TTM) 5.29 16.18 Sequent Scientific Ltd.
Enterprise Value $55.23B $1,635.46B Divi's Laboratories Ltd.
EV/Revenue Ratio 3.33 15.86 Sequent Scientific Ltd.
Gross Profit Margin (TTM) 54.46% 63.71% Divi's Laboratories Ltd.
Revenue per Share (TTM) $66 $388 Divi's Laboratories Ltd.
Earnings per Share (Diluted) $1.63 $93.66 Divi's Laboratories Ltd.
Beta (Stock Volatility) 0.96 0.19 Divi's Laboratories Ltd.

Sequent Scientific Ltd. vs Divi's Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

SEQUENT
DIVISLAB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Sequent Scientific Ltd.0.54%-0.20%11.92%29.09%19.28%20.60%
Divi's Laboratories Ltd.-0.44%1.34%-2.25%8.85%4.11%4.17%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Sequent Scientific Ltd.26.71%229.31%-7.05%107.29%69.54%69.54%
Divi's Laboratories Ltd.-0.43%85.44%58.15%496.33%1,610.60%10,946.76%

Performance & Financial Health Analysis: Sequent Scientific Ltd. vs Divi's Laboratories Ltd.

MetricSEQUENTDIVISLAB
Market Information
Market Cap i₹84.41B₹1.69T
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i762,004253,443
90 Day Avg. Volume i791,567283,911
Last Close₹251.30₹6,608.50
52 Week Range₹166.00 - ₹277.35₹5,636.50 - ₹7,071.50
% from 52W High-9.39%-6.55%
All-Time High₹336.50 (Jun 28, 2021)₹7,071.50 (Jul 08, 2025)
% from All-Time High-25.32%-6.55%
Growth Metrics
Quarterly Revenue Growth0.15%0.12%
Quarterly Earnings Growth4.65%-0.01%
Financial Health
Profit Margin (TTM) i0.03%0.24%
Operating Margin (TTM) i0.10%0.30%
Return on Equity (TTM) i0.07%0.15%
Debt to Equity (MRQ) i55.310.58
Cash & Liquidity
Book Value per Share (MRQ)₹32.38₹580.95
Cash per Share (MRQ)₹2.84₹122.95
Operating Cash Flow (TTM) i₹1.04B₹19.67B
Levered Free Cash Flow (TTM) i₹-14,897,500₹21.91B
Dividends
Last 12-Month Dividend Yield iN/A0.91%
Last 12-Month Dividend i₹0.00₹60.00

Valuation & Enterprise Metrics Analysis: Sequent Scientific Ltd. vs Divi's Laboratories Ltd.

MetricSEQUENT (Mar 28, 2026)DIVISLAB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i123.4267.11
Forward P/E i39.8453.75
PEG Ratio i0.234.63
Price to Sales (TTM) i5.2916.18
Price to Book (MRQ) i6.2110.82
Market Capitalization
Market Capitalization i₹84.41B₹1.69T
Enterprise Value i₹55.23B₹1.64T
Enterprise Value Metrics
Enterprise to Revenue i3.3315.86
Enterprise to EBITDA i30.0448.63
Risk & Other Metrics
Beta i0.960.19
Book Value per Share (MRQ) i₹32.38₹580.95

Financial Statements Comparison: Sequent Scientific Ltd. vs Divi's Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSEQUENT (2025)DIVISLAB (2025)
Revenue/Sales i15.47B93.25B
Cost of Goods Sold i8.64B38.70B
COGS % of Revenue i55.9%41.5%
Gross Profit i6.83B54.55B
Gross Margin i44.1%58.5%
Research & Development iN/A270.00M
Operating Income (EBIT) i1.19B25.71B
Operating Margin i7.7%27.6%
EBITDA i1.63B33.19B
EBITDA Margin i10.5%35.6%
Pre-Tax Income i443.06M29.16B
Pre-Tax Income % of Revenue i2.9%31.3%
Income Tax i120.47M7.25B
Income Tax % of Revenue i0.8%7.8%
Net Income (Profit) i322.59M21.91B
Profit Margin i2.1%23.5%

Balance Sheet & Liquidity Metrics

MetricSEQUENT (2025)DIVISLAB (2025)
Cash & Equivalents i626.60M4.15B
Total Current Assets i8.74B100.81B
Total Current Assets % of Revenue i56.5%108.1%
Total Current Liabilities i5.05B14.52B
Total Current Liabilities % of Revenue i32.6%15.6%
Long-Term Debt i3.00B20.00M
Long-Term Debt % of Revenue i19.4%0.0%
Total Shareholders Equity i7.70B149.69B
Retained Earnings i1.25B134.00B
Retained Earnings % of Revenue i8.1%143.7%
Property, Plant & Equipment i2.84B3.19B

Cash Flow Statement Comparison

MetricSEQUENT (2025)DIVISLAB (2025)
Operating Cash Flow i360.47M19.67B
Operating Cash Flow % of Revenue i2.3%21.1%
Capital Expenditures i-293.87M-14.38B
Free Cash Flow i442.73M2.15B
FCF Margin i2.9%2.3%
Debt Repayment i-1.88BN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSEQUENTDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i435.72M265.47M
Float Shares i96.00M117.72M
% Held by Insiders i68.03%52.04%
% Held by Institutions i7.40%28.65%
% Held by Public i24.57%19.31%

Dividend Analysis & Yield Comparison: Sequent Scientific Ltd. vs Divi's Laboratories Ltd.

MetricSEQUENTDIVISLAB
Last 12-Month Dividend i₹0.00₹60.00
Last 12-Month Dividend Yield iN/A0.91%
3-Year Avg Annual Dividend i₹0.00₹50.00
3-Year Avg Dividend Yield iN/A0.70%
3-Year Total Dividends i₹0.00₹150.00
Ex-Dividend DateN/AJul 25, 2025